URB1
gene geneOn this page
Also known as KIAA0539NPA1
Summary
URB1 (URB1 ribosome biogenesis factor, HGNC:17344) is a protein-coding gene on chromosome 21q22.11, encoding Nucleolar pre-ribosomal-associated protein 1 (O60287). It is a common-essential gene (DepMap: required in 98.4% of cancer cell lines).
Enables RNA binding activity. Predicted to be involved in maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) and maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA). Located in fibrillar center.
Source: NCBI Gene 9875 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 439 total
- Cancer dependency (DepMap): dependent in 98.4% of screened cell lines (common-essential)
- MANE Select transcript:
NM_014825
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17344 |
| Approved symbol | URB1 |
| Name | URB1 ribosome biogenesis factor |
| Location | 21q22.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA0539, NPA1 |
| Ensembl gene | ENSG00000142207 |
| Ensembl biotype | protein_coding |
| OMIM | 608865 |
| Entrez | 9875 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000382751, ENST00000480196, ENST00000492603, ENST00000864001, ENST00000913255, ENST00000947585
RefSeq mRNA: 1 — MANE Select: NM_014825
NM_014825
CCDS: CCDS46645
Canonical transcript exons
ENST00000382751 — 39 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000952905 | 32333317 | 32333419 |
| ENSE00001042861 | 32345374 | 32345575 |
| ENSE00001042862 | 32357537 | 32357656 |
| ENSE00001042866 | 32373647 | 32373772 |
| ENSE00001042868 | 32341466 | 32341524 |
| ENSE00001042870 | 32322478 | 32322584 |
| ENSE00001042871 | 32346956 | 32347811 |
| ENSE00001042875 | 32350704 | 32350922 |
| ENSE00001042879 | 32363156 | 32363329 |
| ENSE00001042882 | 32317676 | 32317917 |
| ENSE00001042885 | 32349304 | 32349483 |
| ENSE00001042891 | 32366618 | 32366755 |
| ENSE00001042896 | 32375398 | 32375483 |
| ENSE00001042904 | 32378445 | 32378541 |
| ENSE00001042917 | 32361892 | 32362021 |
| ENSE00001042926 | 32337404 | 32337514 |
| ENSE00001042928 | 32354859 | 32354997 |
| ENSE00001042932 | 32344570 | 32344756 |
| ENSE00001042937 | 32372507 | 32372631 |
| ENSE00001042940 | 32384313 | 32384464 |
| ENSE00001042942 | 32368403 | 32368598 |
| ENSE00001042944 | 32324491 | 32324602 |
| ENSE00001042947 | 32361007 | 32361123 |
| ENSE00001042951 | 32316466 | 32317065 |
| ENSE00001042954 | 32353933 | 32354103 |
| ENSE00001042957 | 32325229 | 32325389 |
| ENSE00001042963 | 32355449 | 32355565 |
| ENSE00001042969 | 32319217 | 32319414 |
| ENSE00001042971 | 32359796 | 32359908 |
| ENSE00001042973 | 32320531 | 32320640 |
| ENSE00001042974 | 32383422 | 32383554 |
| ENSE00001042983 | 32385545 | 32385684 |
| ENSE00001042988 | 32338707 | 32338900 |
| ENSE00001042993 | 32321801 | 32321944 |
| ENSE00001042998 | 32352710 | 32352906 |
| ENSE00001178996 | 32337094 | 32337157 |
| ENSE00001493247 | 32311018 | 32315099 |
| ENSE00001493352 | 32392769 | 32393012 |
| ENSE00003525489 | 32334163 | 32334334 |
Expression profiles
Bgee: expression breadth ubiquitous, 221 present calls, max score 92.35.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 34.5152 / max 357.5144, expressed in 1812 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 190182 | 28.8888 | 1809 |
| 190181 | 5.3508 | 1519 |
| 209295 | 0.1925 | 104 |
| 190179 | 0.0831 | 50 |
Top tissues by expression
275 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| endothelial cell | CL:0000115 | 92.35 | gold quality |
| stromal cell of endometrium | CL:0002255 | 83.16 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 82.31 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.87 | gold quality |
| body of uterus | UBERON:0009853 | 81.23 | gold quality |
| sural nerve | UBERON:0015488 | 81.10 | gold quality |
| adrenal tissue | UBERON:0018303 | 80.99 | gold quality |
| cortical plate | UBERON:0005343 | 80.39 | gold quality |
| thoracic aorta | UBERON:0001515 | 80.22 | gold quality |
| ascending aorta | UBERON:0001496 | 80.21 | gold quality |
| ventricular zone | UBERON:0003053 | 80.07 | gold quality |
| gastrocnemius | UBERON:0001388 | 79.75 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 79.69 | gold quality |
| right uterine tube | UBERON:0001302 | 79.58 | gold quality |
| left adrenal gland | UBERON:0001234 | 78.83 | gold quality |
| muscle of leg | UBERON:0001383 | 78.82 | gold quality |
| prostate gland | UBERON:0002367 | 78.82 | gold quality |
| left ovary | UBERON:0002119 | 78.57 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 78.54 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 78.54 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 78.47 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 78.31 | gold quality |
| lower esophagus | UBERON:0013473 | 78.29 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 78.09 | gold quality |
| right ovary | UBERON:0002118 | 78.07 | gold quality |
| ovary | UBERON:0000992 | 77.88 | gold quality |
| vagina | UBERON:0000996 | 77.83 | gold quality |
| right adrenal gland | UBERON:0001233 | 77.79 | gold quality |
| adrenal gland | UBERON:0002369 | 77.69 | gold quality |
| tibial nerve | UBERON:0001323 | 77.61 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 6.43 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
78 targeting URB1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-605-3P | 99.88 | 69.22 | 1833 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-3934-5P | 99.67 | 64.04 | 846 |
| HSA-MIR-6887-3P | 99.66 | 67.83 | 1778 |
| HSA-MIR-378A-5P | 99.65 | 66.33 | 1311 |
| HSA-MIR-4666B | 99.64 | 68.69 | 1282 |
| HSA-MIR-4761-5P | 99.51 | 66.69 | 804 |
| HSA-MIR-186-3P | 99.51 | 66.24 | 1685 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 98.4% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 2)
- RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1. (PMID:31886628)
- Ribosome assembly factor URB1 contributes to colorectal cancer proliferation through transcriptional activation of ATF4. (PMID:32888357)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | urb1 | ENSDARG00000060308 |
| mus_musculus | Urb1 | ENSMUSG00000039929 |
| rattus_norvegicus | Urb1 | ENSRNOG00000002080 |
| drosophila_melanogaster | CG12499 | FBGN0038968 |
| caenorhabditis_elegans | WBGENE00020273 |
Protein
Protein identifiers
Nucleolar pre-ribosomal-associated protein 1 — O60287 (reviewed: O60287)
Alternative names: Nucleolar protein 254 kDa, URB1 ribosome biogenesis 1 homolog
All UniProt accessions (1): O60287
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus. Nucleolus.
RefSeq proteins (1): NP_055640* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR016024 | ARM-type_fold | Homologous_superfamily |
| IPR021714 | URB1_N | Domain |
| IPR032436 | URB1_C | Domain |
| IPR039844 | URB1 | Family |
| IPR059018 | HEAT_URB1 | Domain |
Pfam: PF11707, PF16201, PF26140
UniProt features (8 total): region of interest 2, modified residue 2, sequence variant 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O60287-F1 | 75.57 | 0.07 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 17, 1143
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 80 (showing top):
GOBP_RIBOSOME_BIOGENESIS, ONKEN_UVEAL_MELANOMA_UP, GOBP_MATURATION_OF_5_8S_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA, GOBP_MATURATION_OF_LSU_RRNA, GOBP_MATURATION_OF_5_8S_RRNA, chr21q22, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GOBP_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS, GOCC_NUCLEOLUS, MANALO_HYPOXIA_DN, GOBP_MATURATION_OF_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA, LEE_BMP2_TARGETS_DN, GOCC_FIBRILLAR_CENTER, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, E2F3_UP.V1_DN
GO Biological Process (2): maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463), maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)
GO Molecular Function (1): RNA binding (GO:0003723)
GO Cellular Component (3): fibrillar center (GO:0001650), nucleolus (GO:0005730), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| maturation of LSU-rRNA | 1 |
| maturation of 5.8S rRNA | 1 |
| nucleic acid binding | 1 |
| nucleolus | 1 |
| cellular anatomical structure | 1 |
| nuclear lumen | 1 |
| intracellular membraneless organelle | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1664 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| URB1 | URB2 | Q14146 | 860 |
| URB1 | PDCD11 | Q14690 | 718 |
| URB1 | NOL9 | Q5SY16 | 646 |
| URB1 | RBM34 | P42696 | 618 |
| URB1 | EVA1C | P58658 | 587 |
| URB1 | TMEM242 | Q9NWH2 | 562 |
| URB1 | GNL2 | Q13823 | 554 |
| URB1 | CRYZL1 | O95825 | 551 |
| URB1 | HUNK | P57058 | 549 |
| URB1 | CEBPZ | Q03701 | 541 |
| URB1 | LTV1 | Q96GA3 | 534 |
| URB1 | MIS18A | Q9NYP9 | 518 |
| URB1 | DDX51 | Q8N8A6 | 505 |
| URB1 | UTP14A | Q9BVJ6 | 498 |
| URB1 | DHX15 | O43143 | 493 |
IntAct
158 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MECP2 | KPNA3 | psi-mi:“MI:0914”(association) | 0.640 |
| NPM1 | NVL | psi-mi:“MI:0914”(association) | 0.610 |
| NPM1 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.610 |
| PLEKHO1 | UBA6 | psi-mi:“MI:0914”(association) | 0.530 |
| FGF3 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MECP2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF512 | ZNF724 | psi-mi:“MI:0914”(association) | 0.530 |
| RBM34 | NVL | psi-mi:“MI:0914”(association) | 0.530 |
| RRP8 | NVL | psi-mi:“MI:0914”(association) | 0.530 |
| RPL18 | NOP56 | psi-mi:“MI:0914”(association) | 0.530 |
| MACROH2A2 | PPM1G | psi-mi:“MI:0914”(association) | 0.530 |
| RPL18A | RRP8 | psi-mi:“MI:0914”(association) | 0.530 |
| MAGEB2 | POLRMT | psi-mi:“MI:0914”(association) | 0.530 |
| CCDC59 | GAPDHS | psi-mi:“MI:0914”(association) | 0.530 |
| RBM4 | NVL | psi-mi:“MI:0914”(association) | 0.530 |
| MAGEB2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| RRP8 | MAGEB2 | psi-mi:“MI:0914”(association) | 0.530 |
| ABT1 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ILVBL | SLC33A1 | psi-mi:“MI:0914”(association) | 0.530 |
| RPLP0 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| DDX21 | MED19 | psi-mi:“MI:2364”(proximity) | 0.480 |
BioGRID (183): URB1 (Affinity Capture-RNA), URB1 (Affinity Capture-MS), URB1 (Affinity Capture-MS), URB1 (Affinity Capture-MS), URB1 (Affinity Capture-MS), URB1 (Affinity Capture-MS), URB1 (Affinity Capture-MS), URB1 (Affinity Capture-MS), URB1 (Affinity Capture-MS), URB1 (Affinity Capture-MS), URB1 (Affinity Capture-MS), URB1 (Affinity Capture-MS), URB1 (Affinity Capture-MS), URB1 (Affinity Capture-MS), URB1 (Affinity Capture-MS)
ESM2 similar proteins: A0A0B4K859, A1Z7L1, A1ZBE8, A8WTE8, F4JC97, F4KBW6, F6S215, F6WXT2, O13665, O60287, O75691, P34343, P40090, P42173, P48322, P49815, P49816, P78527, P78847, Q03280, Q09716, Q21106, Q571H0, Q5SRE5, Q5WNI9, Q61037, Q6ZQH8, Q750S2, Q8BH53, Q8IQV9, Q8MYL1, Q8QGX4, Q8WN22, Q93903, Q95YE9, Q9C8Z4, Q9DEI1, Q9FIN7, Q9HDV6, Q9P7M6
Diamond homologs: O60287, Q571H0
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 176 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| rRNA modification in the nucleus and cytosol | 8 | 14.0× | 3e-06 |
| Peptide chain elongation | 11 | 13.0× | 1e-07 |
| Viral mRNA Translation | 11 | 13.0× | 1e-07 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 11 | 12.9× | 1e-07 |
| Selenocysteine synthesis | 11 | 12.4× | 1e-07 |
| Eukaryotic Translation Termination | 11 | 12.4× | 1e-07 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 11 | 12.1× | 1e-07 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | 11 | 12.1× | 1e-07 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| ribosomal large subunit biogenesis | 7 | 20.7× | 9e-06 |
| cytoplasmic translation | 12 | 14.8× | 2e-08 |
| ribosomal small subunit biogenesis | 8 | 12.2× | 5e-05 |
| rRNA processing | 12 | 11.3× | 3e-07 |
| negative regulation of translation | 7 | 9.1× | 2e-03 |
| translation | 13 | 8.9× | 8e-07 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
439 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 354 |
| Likely benign | 46 |
| Benign | 7 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
6123 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:32314946:T:TA | donor_gain | 1.0000 |
| 21:32316460:CCTTA:C | donor_loss | 1.0000 |
| 21:32316461:CTTAC:C | donor_loss | 1.0000 |
| 21:32316462:TTA:T | donor_loss | 1.0000 |
| 21:32316463:TA:T | donor_loss | 1.0000 |
| 21:32317674:A:AC | donor_gain | 1.0000 |
| 21:32317674:ACT:A | donor_gain | 1.0000 |
| 21:32317675:C:CA | donor_gain | 1.0000 |
| 21:32317675:CT:C | donor_gain | 1.0000 |
| 21:32317675:CTC:C | donor_gain | 1.0000 |
| 21:32319212:CTCA:C | donor_loss | 1.0000 |
| 21:32319213:TCA:T | donor_loss | 1.0000 |
| 21:32319214:CA:C | donor_loss | 1.0000 |
| 21:32319215:A:AC | donor_gain | 1.0000 |
| 21:32319216:C:CC | donor_gain | 1.0000 |
| 21:32319216:C:T | donor_loss | 1.0000 |
| 21:32319216:CCT:C | donor_gain | 1.0000 |
| 21:32319361:CACAG:C | acceptor_gain | 1.0000 |
| 21:32319412:AACC:A | acceptor_loss | 1.0000 |
| 21:32319415:C:CA | acceptor_loss | 1.0000 |
| 21:32320529:A:AC | donor_gain | 1.0000 |
| 21:32320530:C:CA | donor_gain | 1.0000 |
| 21:32320530:CT:C | donor_gain | 1.0000 |
| 21:32320530:CTT:C | donor_gain | 1.0000 |
| 21:32320530:CTTG:C | donor_gain | 1.0000 |
| 21:32320636:CAATT:C | acceptor_gain | 1.0000 |
| 21:32320639:TT:T | acceptor_gain | 1.0000 |
| 21:32320639:TTCTG:T | acceptor_loss | 1.0000 |
| 21:32320640:TC:T | acceptor_loss | 1.0000 |
| 21:32320641:C:CC | acceptor_gain | 1.0000 |
AlphaMissense
14820 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:32353997:A:C | S784R | 0.996 |
| 21:32353997:A:T | S784R | 0.996 |
| 21:32353999:T:G | S784R | 0.996 |
| 21:32368432:A:G | W390R | 0.996 |
| 21:32368432:A:T | W390R | 0.996 |
| 21:32372536:A:C | F324L | 0.996 |
| 21:32372536:A:T | F324L | 0.996 |
| 21:32372538:A:G | F324L | 0.996 |
| 21:32355514:A:G | W681R | 0.995 |
| 21:32355514:A:T | W681R | 0.995 |
| 21:32368524:A:G | L359P | 0.995 |
| 21:32375408:A:G | L247P | 0.994 |
| 21:32372546:C:T | G321E | 0.993 |
| 21:32372576:A:G | L311P | 0.993 |
| 21:32373747:T:A | K259I | 0.993 |
| 21:32334324:A:G | W1566R | 0.992 |
| 21:32334324:A:T | W1566R | 0.992 |
| 21:32359810:A:G | W619R | 0.991 |
| 21:32359810:A:T | W619R | 0.991 |
| 21:32373685:A:G | W280R | 0.991 |
| 21:32373685:A:T | W280R | 0.991 |
| 21:32373746:T:A | K259N | 0.991 |
| 21:32373746:T:G | K259N | 0.991 |
| 21:32384424:C:G | R108P | 0.991 |
| 21:32368589:G:C | N337K | 0.990 |
| 21:32368589:G:T | N337K | 0.990 |
| 21:32384433:A:T | I105K | 0.990 |
| 21:32372567:A:G | L314P | 0.989 |
| 21:32383531:A:G | L153P | 0.989 |
| 21:32383537:A:G | L151P | 0.989 |
dbSNP variants (sampled 300 via entrez): RS1000089116 (21:32383281 G>A), RS1000180123 (21:32312570 G>A), RS1000185628 (21:32334861 C>T), RS1000214938 (21:32388466 C>T), RS1000259601 (21:32350904 T>A,C), RS1000268913 (21:32388672 C>A), RS1000297595 (21:32339831 C>G,T), RS1000312073 (21:32391300 A>G), RS1000334838 (21:32362037 A>C), RS1000405376 (21:32378766 T>G), RS1000411239 (21:32327726 G>C), RS1000416407 (21:32318380 G>A), RS1000434787 (21:32383035 C>A,T), RS1000471032 (21:32361773 G>A,C), RS1000509944 (21:32329978 A>C)
Disease associations
OMIM: gene MIM:608865 | disease phenotypes: MIM:607398
GenCC curated gene-disease
Mondo (1): glucocorticoid deficiency 2 (MONDO:0011826)
Orphanet (1): Familial glucocorticoid deficiency (Orphanet:361)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C564577 | Glucocorticoid Deficiency 2 (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol S | increases methylation, affects cotreatment, decreases expression | 2 |
| Estradiol | increases expression | 2 |
| Aflatoxin B1 | decreases methylation, increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol F | affects cotreatment, decreases expression | 1 |
| dicrotophos | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects cotreatment, decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| potassium chromate(VI) | increases expression | 1 |
| pentabromodiphenyl ether | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cisplatin | decreases expression | 1 |
| Dexamethasone | affects cotreatment, decreases expression | 1 |
| Dinitrochlorobenzene | affects binding | 1 |
| Doxorubicin | decreases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Ribonucleotides | affects binding | 1 |
| Tretinoin | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| Fatty Acids, Omega-3 | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Fatty Acids, Omega-6 | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): glucocorticoid deficiency 2